Director

Carrie L. Anderson

Director·Embecta Corp.

About

Ms. Anderson served as the Executive Vice President and Chief Financial Officer for The Campbell's Company (NASDAQ: CPB) until October 2025. Prior to joining Campbell's in 2023, Ms. Anderson served as Executive Vice President and Chief Financial Officer for Integra LifeSciences Holdings Corporation (NASDAQ: IART). Prior to joining Integra in June 2019, she was Vice President and Controller of Dover Corporation. Ms. Anderson brings to the Board her financial expertise, life sciences experience and experience working with large, diversified global manufacturing companies, as well as her extensive experience in executive leadership, strategy and innovation, risk and crisis management, consumer/retail, ESG and experience with institutional investors.

Since 2022
Tenure 4 yrs

Also at Embecta Corp.

RH Robert (Bob) J. Hombach Director DK Devdatt (Dev) Kurdikar President and Chief Executive Officer, Embecta Corp. MP Milton M. Morris, Ph.D. Director CM Claire Pomeroy, M.D. Director (Lead Director effective as of the 2026 Annual Meeting) KP Karen N. Prange Director CR Christopher R. Reidy Director

Past roles

No prior roles disclosed
The proxy statement discloses no roles beyond this person's current position. Disclosure is required only for the most recent five years.

Director compensation

Data from FY 2025
Fees earned or paid in cash
$80,000
Stock awards
$230,004
All other compensation
$7,000
Total
$317,004

Related

Source: Embecta Corp. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo